Clinical Trials Logo

Clinical Trial Summary

The study is the second phase of Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke (ANGEL-ACT).

During the first phase of the ANGEL-ACT (NCT03370939, a prospective multi-center registry study), problems and difficulties in the emergency work flow of acute ischemic stroke care in China have been identified, such as inadequate pre-hospital notification, delay of in-hospital diagnosis and treatment, difficulty in treatment consent, lack of professional training of endovascular treatment,etc., especially in the delay of in-hospital diagnosis and treatment.

ANGEL-ACT II is a cluster randomized, parallel controlled study. The aim of this study was to evaluate the effectiveness of multi-modal medical quality improvement measures on the delay of hospital-level emergency work flow of acute ischemic stroke management as well as its impact on patient prognosis. The interventional measures include emergency work flow management app on smartphone, specialized training, assessment of quality improvement outcomes and feedback on a regular basis.


Clinical Trial Description

This is a prospective, multi-centre, cluster randomized, open label, parallel controlled study that enrolled patients with acute ischemic stroke who underwent endovascular treatment in about 34 hospitals in China. The ratio Interventional arm control arm is 1:1, which means 17 hospitals and 332 participants in each arm. ;


Study Design


Related Conditions & MeSH terms

  • Infarction
  • Intracranial Artery Occlusion With Infarction (Disorder)

NCT number NCT04151589
Study type Interventional
Source Beijing Tiantan Hospital
Contact
Status Recruiting
Phase N/A
Start date August 22, 2019
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT03370939 - Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke
Recruiting NCT04840719 - RECO in the Endovascular Treatment of Acute Ischemic Stroke